ADMA Biologics Inc
ADMA
4
|
$6.535
5.4%
5.13%
2.7M
|
Health Technology
(0.0% 1d) (-3.0% 1m) (80.2% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-32.54% volume)
Earnings Calendar: 2022-08-10
Market Cap: $ 1,514,626,903
http://www.admabiologics.com
Sec Filling | Patents | 314 employees
ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in the manufacturing, marketing and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment comprises of the immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 2, 2006 and is headquartered in Hackensack, NJ.
msa
add to watch list Paper trade email alert is off
Press-releases
ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM®
Published: 2024-03-11 (Crawled : 11:00) - globenewswire.com
ADMA 4 | $6.535 5.4% 5.13% 2.7M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -2.52%
bivigam fda
ADMA Biologics to Participate in the Raymond James Institutional Investor Conference
Published: 2024-03-05 (Crawled : 12:00) - globenewswire.com
ADMA 4 | $6.535 5.4% 5.13% 2.7M
|
Health Technology
|
| O: -0.35%
H: 2.11%
C: 1.75%
conference
ADMA Biologics Announces CFO Transition
Published: 2024-02-28 (Crawled : 21:00) - globenewswire.com
ADMA 4 | $6.535 5.4% 5.13% 2.7M
|
Health Technology
|
| O: 0.0%
H: 6.32%
C: -0.37%
ADMA Biologics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Published: 2024-02-28 (Crawled : 21:00) - globenewswire.com
ADMA 4 | $6.535 5.4% 5.13% 2.7M
|
Health Technology
|
| O: 0.0%
H: 6.32%
C: -0.37%
business year update financial results
Plasma Therapy Global Market Report 2024 - Projected Compound Annual Growth Rate of 12.5%, with Market Set to Reach $0.88 Billion in 2028
Published: 2024-02-22 (Crawled : 01:00) - prnewswire.com
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: -0.2%
H: 0.14%
C: -0.48%
BAX | $41.02 1.54% 0.0% 2.6M
|
Health Technology
|
| O: -0.38%
H: 0.14%
C: -0.14%
KMDA | $5.1 -0.99% 5.3K
|
Health Technology
|
| O: 2.0%
H: 2.28%
C: 1.63%
ADMA 4 | $6.535 5.4% 5.13% 2.7M
|
Health Technology
|
| O: 0.19%
H: 2.5%
C: 1.35%
report reach global set therapy growth market
ADMA Biologics to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
Published: 2024-02-21 (Crawled : 21:00) - globenewswire.com
ADMA 4 | $6.535 5.4% 5.13% 2.7M
|
Health Technology
|
| O: 0.19%
H: 2.5%
C: 1.35%
report year financial results
ADMA Biologics Successfully Implements Innovative AI Program, Named ADMAlytics
Published: 2024-02-21 (Crawled : 12:00) - globenewswire.com
ADMA 4 | $6.535 5.4% 5.13% 2.7M
|
Health Technology
|
| O: -0.39%
H: 2.53%
C: 0.97%
Plasma Fractionation Market to grow by USD 10.00 billion, 5.81% YOY growth expected in 2024, North America to Experience Maximum Growth - Technavio
Published: 2024-01-26 (Crawled : 03:00) - prnewswire.com
CSLLY | $89.17 3.3% 54K
|
n/a
|
| O: 0.21%
H: 0.22%
C: 0.21%
GIKLY | $4.4 132.75% 150
|
Manufacturing
|
| O: 3.14%
H: 0.0%
C: 0.0%
ACN | News S | $316.83 -0.19% 0.0% 2M
|
Technology Services
|
| O: -0.01%
H: 0.6%
C: -0.23%
KMDA | $5.1 -0.99% 5.3K
|
Health Technology
|
| O: 0.89%
H: 1.05%
C: 0.88%
ADMA 4 | $6.535 5.4% 5.13% 2.7M
|
Health Technology
|
| O: 0.98%
H: 1.36%
C: -0.78%
america expected growth market
ADMA Biologics Announces Preliminary Fourth Quarter 2023 Revenue and Provides Business Update
Published: 2024-01-08 (Crawled : 12:00) - globenewswire.com
ADMA 4 | $6.535 5.4% 5.13% 2.7M
|
Health Technology
|
| O: 6.82%
H: 2.98%
C: 2.34%
business revenue update
ADMA Biologics Announces $135 Million Non-Dilutive Refinancing of Credit Facilities with Ares Management
Published: 2023-12-18 (Crawled : 21:00) - globenewswire.com
ADMA 4 | $6.535 5.4% 5.13% 2.7M
|
Health Technology
|
| O: 1.21%
H: 3.82%
C: 0.72%
management
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Last 48 Hours Insiders Buying
MEGI | $11.975 1.87% 0.04% 140K
|
|
00:30
CTRN P 29000 | $22.25 0.14% 0.13% 100K
|
Retail Trade
|
22:00
CONN | $3.71 1.37% 1.35% 72K
|
Retail Trade
|
21:30
TGEN P 6000 | $0.6897 39.71% 2.3K
|
Utilities
|
18:30
CMTV P 700 | $15.74 17.43% 12K
|
Finance and Insurance
|
18:30
FNB | $13.63 2.17% 0.0% 2.5M
|
Finance
|
17:30
RMCF | $3.57 0.28% 2.8K
|
Consumer Non-Durables
|
20:10